JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on February 26, 2004; DOI: 10.1124/jpet.103.062802


0022-3565/04/3093-1263-1272$20.00
JPET 309:1263-1272, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.062802v1
309/3/1263    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nobe, K.
Right arrow Articles by Momose, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nobe, K.
Right arrow Articles by Momose, K.

CARDIOVASCULAR

Glucose-Dependent Enhancement of Spontaneous Phasic Contraction Is Suppressed in Diabetic Mouse Portal Vein: Association with Diacylglycerol-Protein Kinase C Pathway

Koji Nobe, Hikaru Suzuki, Yasushi Sakai, Hiromi Nobe, Richard J. Paul, and Kazutaka Momose

Department of Pharmacology, School of Pharmaceutical Sciences (K.N., H.S., H.N., K.M.) and Division of Physiology, Department of Occupational Therapy, School of Nursing and Rehabilitation Sciences (Y.S.), Showa University, Tokyo, Japan; and Department of Molecular and Cellular Physiology (R.J.P.), University of Cincinnati College of Medicine, Cincinnati, Ohio

We investigated portal vein (PV) contractility in diabetes using a mouse model (ob/ob mouse) of spontaneous noninsulin-dependent diabetic mellitus. Spontaneous phasic contraction in control mice (C57Bl) was increased in the presence of the thromboxane A2 analog 9,11-dideoxy-11{alpha}, 9{alpha}-epoxymethanoprostaglandin F2{alpha} (U46619) in a time- and concentration-dependent manner. This response was enhanced under high glucose conditions (22.2 mM). Diacylglycerol (DG) was synthesized from glucose and was not affected by phospholipase C (PLC) inhibition under resting conditions in normal glucose. Inhibition of DG-induced PKC activation with 12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo-(2,3-{alpha})pyrrolo(3,4-c)-carbazole (Gö6976), a calcium-dependent protein kinase C (PKC) inhibitor, was only observed under normal glucose conditions. High glucose levels enhanced PLC-independent DG formation followed by an induction of total phosphatidylinositol turnover via calcium-independent PKC activation in C57Bl mice. In ob/ob mice, the high glucose-induced enhancement of PV contraction in response to U46619 was suppressed. These findings suggest that these differences are associated with long-term exposure of tissue to a hyperglycemic state. Under high glucose conditions, DG derived from glucose fell below 50% in C57Bl mice. Moreover, the DG-related calcium-independent PKC was desensitized in ob/ob mice. These results suggest that suppression of the glucose-induced enhancement of PV contraction involves both a decrease in glucose-derived DG formation and reduction of the glucose sensitivity of DG-related PKC.


Received November 10, 2003; accepted February 24, 2004.

Address correspondence to: Dr. Koji Nobe, Department of Pharmacology, School of Pharmaceutical Sciences, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-0555, Japan. E-mail: kojinobe{at}pharm.showa-u.ac.jp




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
K. Nobe, T. Yamazaki, N. Tsumita, T. Hashimoto, and K. Honda
Glucose-Dependent Enhancement of Diabetic Bladder Contraction Is Associated with a Rho Kinase-Regulated Protein Kinase C Pathway
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 940 - 950.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Nobe, T. Yamazaki, T. Kumai, M. Okazaki, S. Iwai, T. Hashimoto, S. Kobayashi, K. Oguchi, and K. Honda
Alterations of Glucose-Dependent and -Independent Bladder Smooth Muscle Contraction in Spontaneously Hypertensive and Hyperlipidemic Rat
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 631 - 642.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Nobe, M. Miyatake, T. Sone, and K. Honda
High-Glucose-Altered Endothelial Cell Function Involves Both Disruption of Cell-to-Cell Connection and Enhancement of Force Development
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 530 - 539.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.